01. History

History of the University of California San Francisco at Mount Zion

Headquartered at the medical center’s Mount Zion campus in San Francisco, California, the Helen Diller Family Comprehensive Cancer Center is the renowned cancer treatment arm of the University of California San Francisco Medical Center (UCSF). Named after a Bay Area philanthropist, the Helen Diller Cancer Center brings together scientists and clinicians from a wide spectrum of backgrounds with one shared goal: preventing and eradicating cancer. Its success has been notable.

A key figure in the history of UCSF’s cancer care was David A. Wood, a respected doctor who served as the first director of the UCSF Cancer Research Institute starting in 1948. Wood brought to his position a belief that to cure cancer, the medical community must take a “multidisciplinary approach, both clinical and basic scientists working together.” This philosophy remains central to the hospital’s beliefs today.

In 1999, UCSF’s cancer center was designated a “comprehensive cancer center” by the National Institutes of Health, the highest possible designation bestowed by the government agency. The title recognized the center for its scientific excellence, diverse research tactics, excellent patient care, and effective outreach activities that seek to prevent as well as control cancer. In 2007, the UCSF cancer center was renamed as the UCFS Helen Diller Family Comprehensive Cancer Center, paying tribute to support from Bay Area resident Helen Diller and her family.

02. Mesothelioma Care

Mesothelioma Care at the University of California San Francisco at Mount Zion

The University of California San Francisco at Mount Zion fully understands diagnosing and treating mesothelioma. They take a careful approach to develop treatment plans unique to the patient’s situation and type of mesothelioma. Patients seeking treatment at this cancer center can also undergo clinical trials.

03. Specializations

University of California San Francisco at Mount Zion Specializations

  • Clinical trials
  • Standard and experimental mesothelioma treatments
04. Mesothelioma Clinical Trials

Mesothelioma Clinical Trials at the University of California San Francisco at Mount Zion

The following clinical trials are in progress or actively recruiting participants at the University of California San Francisco at Mount Zion:

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

Conditions: Carcinoma, Melanoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Mesothelioma, Mesothelioma, Malignant, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Breast Neoplasms, Lung Neoplasms, Carcinoma, Basal Cell, Squamous Cell Carcinoma of Head and Neck, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Neuroendocrine, Thymoma, Small Cell Lung Carcinoma, Anus Neoplasms, Vulvar Neoplasms

Last Updated: April 28, 2021

Status: Recruiting

Locations: Los Angeles, CA. Los Angeles, CA. San Diego, CA. San Francisco, CA. Atlanta, GA. Chicago, IL. Fairway, KS. Detroit, MI. New York, NY. New York, NY. Portland, OR. Philadelphia, PA. Pittsburgh, PA. Houston, TX. Salt Lake City, UT. Charlottesville, VA. Seattle, WA.

Sorry, there are no clinical trials to display